Injectable liraglutide can help obese type 2 diabetics lose weight A daily injection of liraglutide can help obese or overweight patients with type 2 diabetes lose weight if they also follow a low calorie diet and do more exercise, according to research published in JAMA.…
FDA issues new PML warning for fingolimod The US Food and Drug Administration has issued a new safety warning about cases of a rare brain infection in multiple sclerosis patients taking fingolimod (Gilenya).…
First ADHD treatment recommended through EU centralised authorisation procedure Guanfacine (Intuniv) should be an option for treating attention deficit hyperactivity disorder in children and adolescents aged 6–17 years, says the European Medicines Agency.…
First PCSK9 inhibitors approved in Europe and United States The US Food and Drug Administration has approved alirocumab (Praluent), days after evolocumab (Repatha) became the first PCSK9 inhibitor to be approved in the world.…
Clinical Pharmacist’s monthly news round-up: the top 10 in the past month What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.…
Attacking cancer: are therapeutic vaccines on the verge of fulfilling their potential? Researchers are investigating whether priming the immune system with therapeutic vaccines can prompt the body’s own defences to spring into action against cancer.…
European Medicines Agency launches safety review of HPV vaccines A safety review of human papillomavirus vaccines, which protect young women against cervical cancer, has been launched by the European Medicines Agency.…
Nivolumab granted positive scientific opinion under UK early access scheme Nivolumab, a new lung cancer drug, has been granted a positive scientific opinion by the UK medicines safety regulator under the Early Access to Medicines Scheme (EAMS).…
EMA recommends measures to help patients use adrenaline auto-injectors correctly The European Medicines Agency is recommending a raft of new measures to help educate patients and carers on the proper use of adrenaline auto-injectors.…
Panobinostat set for approval in Europe as multiple myeloma treatment The multiple myeloma drug panobinostat has received a positive opinion from the European Medicines Agency for the treatment of relapsed or refractory disease.…